BLTE
Belite Bio, Inc American Depositary Shares
Nasdaq · usd
Belite Bio, Inc American Depositary Shares (BLTE) trades at $154.74 (+2.97%) as of 7:30:02 PM EDT on Oct 30, 2026, -5.06% over the past month. Market cap is $6.23B, with 7.1 days to cover in short interest.
Stock performance
How Belite Bio, Inc American Depositary Shares (BLTE) stock has performed from one day to one year, with its 52-week range.
- 1D
- +2.97%
- 1W
- +5.03%
- 1M
- -5.06%
- YTD
- -3.26%
- 1Y
- +37.67%
- 52-wk range
- $102.00 – $200.00
Key statistics
Today's trading snapshot for BLTE: day range, open, previous close, volume and market cap.
- Day range
- $146.90 – $156.33
- Open
- $148.79
- Prev close
- $150.28
- Volume
- 234.88K
- Market cap
- $6.23B
- Shares out
- 40.27M
BLTE short interest
How heavily BLTE is shorted: shares short, days to cover and average daily volume.
- Days to cover
- 7.1
- Short interest
- 1.27M
- Avg volume
- 178.36K
As of · reported to FINRA twice monthly.
BLTE news
The latest news and headlines about Belite Bio, Inc American Depositary Shares (BLTE).
- Belite Bio Announces Uplisting to the Nasdaq Global Select MarketpositiveGlobeNewswire Inc.· Oct 19, 2026
- Belite Bio to Host Virtual Commercial Day on September 2, 2026positiveGlobeNewswire Inc.· Aug 24, 2026
- Belite Bio to Participate in the Piper Sandler Virtual Ophthalmology Investor SymposiumpositiveGlobeNewswire Inc.· Jul 6, 2026
- Belite Bio Completes Rolling Submission of New Drug Application to U.S. Food and Drug Administration for Tinlarebant for the Treatment of Stargardt Disease Type 1positiveGlobeNewswire Inc.· Jun 12, 2026
- Belite Bio Reports Unaudited First Quarter 2026 Financial Results and Provides a Corporate UpdatepositiveGlobeNewswire Inc.· May 20, 2026
Frequently asked questions
What is the Belite Bio, Inc American Depositary Shares (BLTE) stock price today?
Belite Bio, Inc American Depositary Shares (BLTE) is trading at $154.74 (+2.97% on the day) as of 7:30:02 PM EDT on Oct 30, 2026. Prices are delayed at least 15 minutes; real-time quotes are available from the Massive API.
What is Belite Bio, Inc American Depositary Shares?
Belite Bio Inc is a clinical stage biopharmaceutical drug development company focused on advancing novel therapeutics targeting degenerative retinal diseases which have unmet medical need such as Geographic Atrophy (GA), the late atrophic (dry) form of age-related macular…
What is the short interest in BLTE?
As of Oct 15, 2026, BLTE has 1.27M shares short and 7.1 days to cover.
What exchange is BLTE listed on?
Belite Bio, Inc American Depositary Shares (BLTE) trades on Nasdaq in USD.
Build with AI
Build an analysis of BLTE with your agent
Point Claude or ChatGPT at the Massive MCP server and recreate this page from live data.
Connect the Massive MCP server (API reference: massive.com/docs/llms.txt) and build a BLTE analysis: the latest quote, key ratios (P/E, P/S, ROE), short interest, recent insider activity and the latest news.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.